Ipca Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve Standalone & Consolidated ....
IPCALAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ipca Laboratories has informed BSE that its Board of Directors will meet on 29 May 2025. The key items on the agenda are: (1) approval of Standalone and Consolidated Audited Financial Results for Q4 and the full financial year ended 31 March 2025, and (2) recommendation of the Final Dividend for FY2024-25. The insider trading window remains closed from 1 April 2025 until 48 hours after the results are declared (i.e., till 31 May 2025). This is a standard advance intimation under SEBI LODR Regulation 29, and no actual financial numbers have been disclosed yet.
Investors should watch the 29 May 2025 board meeting outcome for the audited FY25 results and the final dividend declaration, which could influence short-term stock sentiment and dividend yield expectations.